TMDX
Transmedics Group Stock Analysis
AI Rating
- Quality9/10
- Growth↑ 9/10
- Momentum↑ 6/10
TMDX Growth
- Revenue Y/Y↑ 41.20%
- EPS Y/Y↑ 173.74%
- FCF Y/Y↑ 200.11%
TMDX Profitability
- Gross margin ↑ 60.30%
- EPS margin↑ 16.20%
- ROIC↓ 11.50%
TMDX Risk
- Debt / Equity↓ 1.5
- Debt / FCF↓ 0.4
- Interest coverage↑ 7.6
Transmedics Group stock volatility is in-line with the overall market. We give it a Good risk rating.